Vinçent Laroche

779 total citations
17 papers, 262 citations indexed

About

Vinçent Laroche is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Vinçent Laroche has authored 17 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 4 papers in Genetics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Vinçent Laroche's work include Platelet Disorders and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Vinçent Laroche is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Vinçent Laroche collaborates with scholars based in Canada and United States. Vinçent Laroche's co-authors include Gary Moroff, Diane Kadidlo, David H. McKenna, Jeffrey McCullough, Jacob Pendergrast, Donald R. Branch, Josep Rodés‐Cabau, Robert DeLarochellière, Éric Dumont and Jean‐Michel Paradis and has published in prestigious journals such as Blood, The American Journal of Cardiology and Experimental Neurology.

In The Last Decade

Vinçent Laroche

17 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vinçent Laroche Canada	9	134	77	63	44	40	17	262
Naoki Tokunaga Japan	10	120 0.9×	25 0.3×	44 0.7×	19 0.4×	29 0.7×	19	301
Federica Irene Grifoni Italy	9	91 0.7×	43 0.6×	88 1.4×	56 1.3×	25 0.6×	23	299
Marcus Vinícius Simões Brazil	12	34 0.3×	124 1.6×	49 0.8×	121 2.8×	61 1.5×	24	369
Kay Uthoff Germany	8	82 0.6×	60 0.8×	8 0.1×	181 4.1×	32 0.8×	15	373
Simona Deplano United Kingdom	5	164 1.2×	38 0.5×	159 2.5×	35 0.8×	10 0.3×	14	286
J Ivánýi Hungary	8	65 0.5×	32 0.4×	88 1.4×	19 0.4×	26 0.7×	53	260
P Vanlieferinghen France	10	55 0.4×	21 0.3×	15 0.2×	132 3.0×	52 1.3×	40	404
F. Hervé France	6	115 0.9×	25 0.3×	21 0.3×	38 0.9×	13 0.3×	7	313
Özlem Bostan Türkiye	12	24 0.2×	145 1.9×	18 0.3×	83 1.9×	77 1.9×	48	336
Patrick Chillet France	9	51 0.4×	11 0.1×	32 0.5×	36 0.8×	27 0.7×	19	356

Countries citing papers authored by Vinçent Laroche

Since Specialization

Citations

This map shows the geographic impact of Vinçent Laroche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinçent Laroche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinçent Laroche more than expected).

Fields of papers citing papers by Vinçent Laroche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinçent Laroche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinçent Laroche. The network helps show where Vinçent Laroche may publish in the future.

Co-authorship network of co-authors of Vinçent Laroche

This figure shows the co-authorship network connecting the top 25 collaborators of Vinçent Laroche. A scholar is included among the top collaborators of Vinçent Laroche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinçent Laroche. Vinçent Laroche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Deschênes‐Simard, Xavier, Frédéric Barabé, Vinçent Laroche, et al.. (2024). Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study. Leukemia & lymphoma. 65(13). 1974–1982. 2 indexed citations

Barabé, Frédéric, Vinçent Laroche, Geneviève Gallagher, et al.. (2022). Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study. Blood. 140(Supplement 1). 3304–3305. 1 indexed citations

Brossard, Josée, Sharon Abish, Denis Soulières, et al.. (2021). COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry. Blood. 138(Supplement 1). 4064–4064. 3 indexed citations

Maynard, Mark E., John B. Redell, Nobuhide Kobori, et al.. (2019). Loss of PTEN-induced kinase 1 (Pink1) reduces hippocampal tyrosine hydroxylase and impairs learning and memory. Experimental Neurology. 323. 113081–113081. 12 indexed citations

Ureña, Marina, María Del Trigo, Omar Abdul‐Jawad Altisent, et al.. (2017). Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial. EuroIntervention. 13(1). 44–52. 21 indexed citations

Clark, William F., Ronan Foley, Susan S. Huang, et al.. (2017). TTP: One of the TMA’s—How to sort it out. Transfusion and Apheresis Science. 56(1). 57–58. 3 indexed citations

Sakac, Darinka, et al.. (2016). Optimal conditions for the performance of a monocyte monolayer assay. Transfusion. 56(11). 2680–2690. 24 indexed citations

Laflamme, Jérôme, Rishi Puri, Marina Ureña, et al.. (2015). Incidence and Risk Factors of Hemolysis After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve. The American Journal of Cardiology. 115(11). 1574–1579. 34 indexed citations

Pendergrast, Jacob, et al.. (2015). The role of inflammation in intravenous immune globulin–mediated hemolysis. Transfusion. 55(S2). S65–73. 23 indexed citations

10.

Larochellière, Hugo De, Marina Ureña, Ignacio J. Amat‐Santos, et al.. (2014). Effect on Outcomes and Exercise Performance of Anemia in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement. The American Journal of Cardiology. 115(4). 472–479. 34 indexed citations

11.

Deuson, Robert, et al.. (2012). Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. Journal of Medical Economics. 16(2). 318–326. 10 indexed citations

12.

Rioux‐Massé, Benjamin, Vinçent Laroche, Robert J Bowman, et al.. (2012). The influence of bleeding on trigger changes for platelet transfusion in patients with chemotherapy‐induced thrombocytopenia. Transfusion. 53(2). 306–314. 5 indexed citations

13.

Rioux‐Massé, Benjamin, Vinçent Laroche, Robert J Bowman, et al.. (2011). The Influence of Bleeding on Trigger Changes for Platelet Transfusion in Chemotherapy-Induced Thrombocytopenic Patients. Blood. 118(21). 1260–1260. 1 indexed citations

14.

Laroche, Vinçent, et al.. (2005). Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion. 45(12). 1909–1916. 76 indexed citations

15.

Laroche, Vinçent, et al.. (2004). Review: immunohematologic aspects of allogeneic hematopoietic progenitor cell transplantation. Immunohematology. 20(4). 217–225. 3 indexed citations

16.

Gentilini, M, Vinçent Laroche, & A Degrémont. (1996). [ASPECTS OF PARASITIC AND INFECTIOUS TROPICAL PATHOLOGY IN THE REPUBLIC OF HAITI].. PubMed. 57. 299–306. 8 indexed citations

17.

Laroche, Vinçent. (1965). La leptospirose humaine en Haiti. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact